SBC Medical Group (SBC) Set to Release Earnings on Friday

SBC Medical Group (NASDAQ:SBC – Get Free Report) is expected to be issuing its Q3 2026 results before the market opens on Friday, November 13th. Analysts expect the company to post earnings of $0.11 per share and revenue of $48.90 million for the quarter. Investors can check the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Friday, November 13, 2026 at 8:30 AM ET.

SBC Medical Group (NASDAQ:SBC – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by ($0.02). The company had revenue of $49.19 million for the quarter, compared to the consensus estimate of $45.37 million. SBC Medical Group had a net margin of 27.99% and a return on equity of 18.47%. On average, analysts expect SBC Medical Group to post $0.44 EPS for the current fiscal year and $0.52 EPS for the next fiscal year.

SBC Medical Group Price Performance

SBC stock opened at $5.02 on Friday. The company has a 50 day simple moving average of $4.95 and a 200 day simple moving average of $3.94. The stock has a market cap of $516.29 million, a price-to-earnings ratio of 10.68, a P/E/G ratio of 2.39 and a beta of 0.52. SBC Medical Group has a 1 year low of $2.78 and a 1 year high of $5.79. The company has a debt-to-equity ratio of 0.09, a current ratio of 3.31 and a quick ratio of 3.27.

Analysts Set New Price Targets

A number of analysts have weighed in on SBC shares. BTIG Research restated a “buy” rating and issued a $8.00 target price on shares of SBC Medical Group in a research report on Thursday, August 13th. Wall Street Zen upgraded shares of SBC Medical Group from a “buy” rating to a “strong-buy” rating in a report on Monday, October 5th. Finally, Weiss Ratings upgraded SBC Medical Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $8.00.

Check Out Our Latest Analysis on SBC Medical Group

SBC Medical Group Company Profile

(Get Free Report)

SBC Medical Group Holdings Incorporated is a Japan-based healthcare services company focused on supporting aesthetic medicine and related medical institutions. Through its group companies, the business provides operational and management support designed to help clinics deliver cosmetic surgery, dermatology, and other elective medical services.

The company’s services include clinic management consulting, marketing, staff recruitment and training, procurement, information technology, and administrative support.

See Also

Earnings History for SBC Medical Group (NASDAQ:SBC)

Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.